IBRX icon

ImmunityBio

139 hedge funds and large institutions have $256M invested in ImmunityBio in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 43 increasing their positions, 42 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

2.34% more ownership

Funds ownership: 9.87%12.21% (+2.3%)

2% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 42

22% less call options, than puts

Call options by funds: $3.69M | Put options by funds: $4.76M

Holders
139
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.69M
Puts
$4.76M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
51
$296K
52
$269K
53
$261K
54
$257K
55
$249K
56
$238K
57
$227K
58
$223K
59
$221K
60
$210K
61
$202K
62
$200K
63
$196K
64
$196K
65
$186K
66
$172K
67
$160K
68
$159K
69
$156K
70
$153K
71
$144K
72
$133K
73
$128K
74
$125K
75
$120K